SecBot SecBot
8-K ·Filed Oct 26, 2026

OTLC

Oncotelic Therapeutics, Inc.
NEUTRAL
Impact 2/10
Processed9h 15m ago SEC0001493152-26-048435
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-048435
Document: 0001493152-26-048435-index-headers.html0001493152-26-048435
Document: 0001493152-26-048435-index.html0001493152-26-048435
Document: 0001493152-26-048435.txt0001493152-26-048435
7 reports for OTLC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OTLC — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 2/10
—awaiting T+60——
Oct 13, 2026
13d ago
8-K
NEUTRAL ★ 2/10
$0.0200awaiting T+60—$0.0157 (−21.50%)
Jul 14, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$0.0400 $0.0200▼ −50.00%▼ −52.79%$0.0157 (−60.75%)
Jun 29, 2026
17w ago
8-K
BEARISH ★ 6/10
$0.0400 $0.0245▲ +38.75%▲ +42.59%$0.0157 (+60.75%)
May 5, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$0.0400 $0.0400· 0.00%▼ −2.06%$0.0157 (−60.75%)
Apr 16, 2026
27w ago
8-K
BULLISH ★ 7/10
$0.0400 $0.0360▼ −10.00%▼ −17.05%$0.0157 (−60.75%)
Apr 2, 2026
29w ago
8-K
NEUTRAL ★ 4/10
$0.0400 $0.0400· 0.00%▼ −14.16%$0.0157 (−60.75%)
Showing 7 of 7

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh OTLC Intelligence

Analysis is for subscribers only.

Subscribe for Full Access